from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0100/-

LFCtreatmentdescriptionclass of inhibitor

0.351

Amikacinug/mL Amikacintranslation

0.124

Cap5-10ug/mL Capreomycintranslation

0.514

Rox10-50 ug/mL Roxithromycintranslation

0.036

SM2-5 ug/mL Streptomycintranslation

0.458

Tet5-10 ug/mL Tetracyclinetranslation

-1.807

Rif0.2-5ug/mL Rifampicintranscription

-0.499

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.119

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.089

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.137

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.374

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.112

Econazole10-24 ug/mL Econazole (azole drug)respiration

3.524

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.072

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.270

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.219

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

1.428

NaN30.2-2 mM Sodium aziderespiration

0.535

Nigericin50 uM Nigericinrespiration

-1.146

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.703

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.161

menadione6-10 ug/mL Menadionerespiration

-0.393

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.021

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.624

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.235

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.557

NRP_1Non-replicating persistence stage 1dosRassociated

-0.100

Amp0.2mg/mL AmpicillincellWall

0.199

Cephalexin20-100 ug/mL CephalexincellWall

-0.217

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.046

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.086

EMB10-20 ug/mL EthambutolcellWall

-0.404

Eta12-40 ug/mL EthionamidecellWall

-0.441

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.193

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.027

BZA0.12 mg/mL BenzamidearomaticAmides

0.470

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.034

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.438

H2O24 mM hydrogen peroxideDNAdamaging

0.061

Levo10 ug/mL LevofloxacinDNAdamaging

0.173

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.242

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.466

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.088

Antimycin12.5-50 ug/mL Antimycin A?

0.274

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.372

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.095

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.083

PA8240.2-2 ug/mL PA-824?

-0.126

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.246

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.343

Verapamil50 uM Verapamil?

-0.957

mercaptoethanol2 mM 2-Mercaptoethanol?

1.123

methoxatin10-20 ug/mL Methoxatin?